nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.135	0.248	CbGbCtD
Pimecrolimus—CYP3A4—Triamcinolone—ankylosing spondylitis	0.102	0.188	CbGbCtD
Pimecrolimus—CYP3A4—Betamethasone—ankylosing spondylitis	0.0876	0.161	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—ankylosing spondylitis	0.0864	0.159	CbGbCtD
Pimecrolimus—CYP3A4—Prednisone—ankylosing spondylitis	0.0816	0.15	CbGbCtD
Pimecrolimus—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0509	0.0938	CbGbCtD
Pimecrolimus—Eye infection—Prednisolone—ankylosing spondylitis	0.0106	0.0232	CcSEcCtD
Pimecrolimus—Skin atrophy—Triamcinolone—ankylosing spondylitis	0.00998	0.0219	CcSEcCtD
Pimecrolimus—Skin atrophy—Methylprednisolone—ankylosing spondylitis	0.00996	0.0218	CcSEcCtD
Pimecrolimus—Skin atrophy—Dexamethasone—ankylosing spondylitis	0.00905	0.0198	CcSEcCtD
Pimecrolimus—Skin atrophy—Betamethasone—ankylosing spondylitis	0.00905	0.0198	CcSEcCtD
Pimecrolimus—Eye infection—Betamethasone—ankylosing spondylitis	0.00882	0.0193	CcSEcCtD
Pimecrolimus—Eye infection—Dexamethasone—ankylosing spondylitis	0.00882	0.0193	CcSEcCtD
Pimecrolimus—Skin atrophy—Prednisone—ankylosing spondylitis	0.00789	0.0173	CcSEcCtD
Pimecrolimus—Leukoderma—Prednisolone—ankylosing spondylitis	0.00771	0.0169	CcSEcCtD
Pimecrolimus—Leukaemia—Methotrexate—ankylosing spondylitis	0.00739	0.0162	CcSEcCtD
Pimecrolimus—Leukoderma—Triamcinolone—ankylosing spondylitis	0.00709	0.0155	CcSEcCtD
Pimecrolimus—Ear infection—Triamcinolone—ankylosing spondylitis	0.00709	0.0155	CcSEcCtD
Pimecrolimus—Leukoderma—Methylprednisolone—ankylosing spondylitis	0.00707	0.0155	CcSEcCtD
Pimecrolimus—Leukoderma—Dexamethasone—ankylosing spondylitis	0.00643	0.0141	CcSEcCtD
Pimecrolimus—Leukoderma—Betamethasone—ankylosing spondylitis	0.00643	0.0141	CcSEcCtD
Pimecrolimus—Application site reaction—Triamcinolone—ankylosing spondylitis	0.00643	0.0141	CcSEcCtD
Pimecrolimus—Sinus congestion—Triamcinolone—ankylosing spondylitis	0.00606	0.0133	CcSEcCtD
Pimecrolimus—Lymphoma—Methotrexate—ankylosing spondylitis	0.0057	0.0125	CcSEcCtD
Pimecrolimus—Leukoderma—Prednisone—ankylosing spondylitis	0.0056	0.0123	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Triamcinolone—ankylosing spondylitis	0.00507	0.0111	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Methylprednisolone—ankylosing spondylitis	0.00506	0.0111	CcSEcCtD
Pimecrolimus—Folliculitis—Triamcinolone—ankylosing spondylitis	0.00479	0.0105	CcSEcCtD
Pimecrolimus—Folliculitis—Methylprednisolone—ankylosing spondylitis	0.00478	0.0105	CcSEcCtD
Pimecrolimus—Leukoderma—Methotrexate—ankylosing spondylitis	0.00468	0.0103	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Betamethasone—ankylosing spondylitis	0.0046	0.0101	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Dexamethasone—ankylosing spondylitis	0.0046	0.0101	CcSEcCtD
Pimecrolimus—Folliculitis—Betamethasone—ankylosing spondylitis	0.00435	0.00953	CcSEcCtD
Pimecrolimus—Folliculitis—Dexamethasone—ankylosing spondylitis	0.00435	0.00953	CcSEcCtD
Pimecrolimus—Bacterial infection—Methotrexate—ankylosing spondylitis	0.00431	0.00944	CcSEcCtD
Pimecrolimus—Throat sore—Triamcinolone—ankylosing spondylitis	0.00418	0.00916	CcSEcCtD
Pimecrolimus—Oropharyngeal discomfort—Triamcinolone—ankylosing spondylitis	0.00414	0.00908	CcSEcCtD
Pimecrolimus—Furuncle—Methotrexate—ankylosing spondylitis	0.00406	0.00889	CcSEcCtD
Pimecrolimus—Acne—Prednisolone—ankylosing spondylitis	0.00389	0.00853	CcSEcCtD
Pimecrolimus—Eye irritation—Prednisolone—ankylosing spondylitis	0.00384	0.0084	CcSEcCtD
Pimecrolimus—Viral infection—Prednisolone—ankylosing spondylitis	0.00363	0.00795	CcSEcCtD
Pimecrolimus—Acne—Triamcinolone—ankylosing spondylitis	0.00358	0.00784	CcSEcCtD
Pimecrolimus—Acne—Methylprednisolone—ankylosing spondylitis	0.00357	0.00783	CcSEcCtD
Pimecrolimus—Herpes simplex—Prednisolone—ankylosing spondylitis	0.00356	0.00779	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Methotrexate—ankylosing spondylitis	0.00335	0.00733	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Triamcinolone—ankylosing spondylitis	0.00331	0.00726	CcSEcCtD
Pimecrolimus—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.00331	0.00726	CcSEcCtD
Pimecrolimus—Acne—Betamethasone—ankylosing spondylitis	0.00325	0.00712	CcSEcCtD
Pimecrolimus—Acne—Dexamethasone—ankylosing spondylitis	0.00325	0.00712	CcSEcCtD
Pimecrolimus—Folliculitis—Methotrexate—ankylosing spondylitis	0.00317	0.00693	CcSEcCtD
Pimecrolimus—Herpes simplex—Dexamethasone—ankylosing spondylitis	0.00297	0.0065	CcSEcCtD
Pimecrolimus—Herpes simplex—Betamethasone—ankylosing spondylitis	0.00297	0.0065	CcSEcCtD
Pimecrolimus—Wheezing—Triamcinolone—ankylosing spondylitis	0.00293	0.00641	CcSEcCtD
Pimecrolimus—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.00288	0.0063	CcSEcCtD
Pimecrolimus—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.00287	0.00629	CcSEcCtD
Pimecrolimus—Acne—Prednisone—ankylosing spondylitis	0.00283	0.0062	CcSEcCtD
Pimecrolimus—Viral infection—Prednisone—ankylosing spondylitis	0.00264	0.00577	CcSEcCtD
Pimecrolimus—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.00261	0.00572	CcSEcCtD
Pimecrolimus—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.00261	0.00572	CcSEcCtD
Pimecrolimus—Skin exfoliation—Prednisone—ankylosing spondylitis	0.00227	0.00498	CcSEcCtD
Pimecrolimus—Skin discolouration—Methotrexate—ankylosing spondylitis	0.0022	0.00483	CcSEcCtD
Pimecrolimus—Bone disorder—Methotrexate—ankylosing spondylitis	0.0022	0.00483	CcSEcCtD
Pimecrolimus—Herpes simplex—Methotrexate—ankylosing spondylitis	0.00216	0.00473	CcSEcCtD
Pimecrolimus—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00197	0.00432	CcSEcCtD
Pimecrolimus—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.0019	0.00416	CcSEcCtD
Pimecrolimus—Influenza—Triamcinolone—ankylosing spondylitis	0.00189	0.00414	CcSEcCtD
Pimecrolimus—Asthma—Triamcinolone—ankylosing spondylitis	0.00189	0.00414	CcSEcCtD
Pimecrolimus—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00182	0.00398	CcSEcCtD
Pimecrolimus—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00178	0.0039	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00176	0.00385	CcSEcCtD
Pimecrolimus—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00168	0.00368	CcSEcCtD
Pimecrolimus—Infestation—Methylprednisolone—ankylosing spondylitis	0.00168	0.00368	CcSEcCtD
Pimecrolimus—Face oedema—Prednisone—ankylosing spondylitis	0.00167	0.00365	CcSEcCtD
Pimecrolimus—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00164	0.00359	CcSEcCtD
Pimecrolimus—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00159	0.00348	CcSEcCtD
Pimecrolimus—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.00153	0.00335	CcSEcCtD
Pimecrolimus—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00152	0.00332	CcSEcCtD
Pimecrolimus—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00151	0.00332	CcSEcCtD
Pimecrolimus—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.0015	0.00329	CcSEcCtD
Pimecrolimus—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00149	0.00326	CcSEcCtD
Pimecrolimus—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00149	0.00326	CcSEcCtD
Pimecrolimus—Erythema—Prednisolone—ankylosing spondylitis	0.00143	0.00314	CcSEcCtD
Pimecrolimus—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00141	0.00309	CcSEcCtD
Pimecrolimus—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00136	0.00299	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00136	0.00298	CcSEcCtD
Pimecrolimus—Erythema—Triamcinolone—ankylosing spondylitis	0.00132	0.00289	CcSEcCtD
Pimecrolimus—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00131	0.00288	CcSEcCtD
Pimecrolimus—Erythema—Methylprednisolone—ankylosing spondylitis	0.00131	0.00288	CcSEcCtD
Pimecrolimus—Angioedema—Prednisolone—ankylosing spondylitis	0.00131	0.00287	CcSEcCtD
Pimecrolimus—Breast disorder—Methotrexate—ankylosing spondylitis	0.00131	0.00286	CcSEcCtD
Pimecrolimus—Eye disorder—Betamethasone—ankylosing spondylitis	0.00128	0.00281	CcSEcCtD
Pimecrolimus—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00128	0.00281	CcSEcCtD
Pimecrolimus—Back pain—Triamcinolone—ankylosing spondylitis	0.00127	0.00279	CcSEcCtD
Pimecrolimus—Asthma—Methotrexate—ankylosing spondylitis	0.00125	0.00273	CcSEcCtD
Pimecrolimus—Angioedema—Triamcinolone—ankylosing spondylitis	0.0012	0.00264	CcSEcCtD
Pimecrolimus—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0012	0.00263	CcSEcCtD
Pimecrolimus—Erythema—Dexamethasone—ankylosing spondylitis	0.0012	0.00262	CcSEcCtD
Pimecrolimus—Erythema—Betamethasone—ankylosing spondylitis	0.0012	0.00262	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00117	0.00256	CcSEcCtD
Pimecrolimus—Oedema—Prednisolone—ankylosing spondylitis	0.00117	0.00256	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00116	0.00254	CcSEcCtD
Pimecrolimus—Cough—Triamcinolone—ankylosing spondylitis	0.00115	0.00252	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00114	0.0025	CcSEcCtD
Pimecrolimus—Pneumonia—Methotrexate—ankylosing spondylitis	0.00112	0.00245	CcSEcCtD
Pimecrolimus—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00112	0.00245	CcSEcCtD
Pimecrolimus—Eye disorder—Prednisone—ankylosing spondylitis	0.00112	0.00245	CcSEcCtD
Pimecrolimus—Infestation—Methotrexate—ankylosing spondylitis	0.00111	0.00244	CcSEcCtD
Pimecrolimus—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00111	0.00244	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00111	0.00243	CcSEcCtD
Pimecrolimus—Flushing—Prednisone—ankylosing spondylitis	0.00111	0.00243	CcSEcCtD
Pimecrolimus—Angioedema—Dexamethasone—ankylosing spondylitis	0.00109	0.00239	CcSEcCtD
Pimecrolimus—Angioedema—Betamethasone—ankylosing spondylitis	0.00109	0.00239	CcSEcCtD
Pimecrolimus—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00108	0.00237	CcSEcCtD
Pimecrolimus—Immune system disorder—Prednisone—ankylosing spondylitis	0.00108	0.00237	CcSEcCtD
Pimecrolimus—Oedema—Triamcinolone—ankylosing spondylitis	0.00108	0.00235	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00108	0.00235	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00107	0.00235	CcSEcCtD
Pimecrolimus—Infection—Triamcinolone—ankylosing spondylitis	0.00107	0.00234	CcSEcCtD
Pimecrolimus—Infection—Methylprednisolone—ankylosing spondylitis	0.00107	0.00233	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00105	0.0023	CcSEcCtD
Pimecrolimus—Epistaxis—Methotrexate—ankylosing spondylitis	0.00105	0.0023	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00105	0.0023	CcSEcCtD
Pimecrolimus—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00104	0.00228	CcSEcCtD
Pimecrolimus—Erythema—Prednisone—ankylosing spondylitis	0.00104	0.00228	CcSEcCtD
Pimecrolimus—Malnutrition—Prednisone—ankylosing spondylitis	0.00104	0.00228	CcSEcCtD
Pimecrolimus—Pain—Prednisolone—ankylosing spondylitis	0.001	0.00219	CcSEcCtD
Pimecrolimus—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000992	0.00217	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00098	0.00215	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000977	0.00214	CcSEcCtD
Pimecrolimus—Oedema—Dexamethasone—ankylosing spondylitis	0.000976	0.00214	CcSEcCtD
Pimecrolimus—Oedema—Betamethasone—ankylosing spondylitis	0.000976	0.00214	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000976	0.00214	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000976	0.00214	CcSEcCtD
Pimecrolimus—Infection—Betamethasone—ankylosing spondylitis	0.000969	0.00212	CcSEcCtD
Pimecrolimus—Infection—Dexamethasone—ankylosing spondylitis	0.000969	0.00212	CcSEcCtD
Pimecrolimus—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000965	0.00211	CcSEcCtD
Pimecrolimus—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000963	0.00211	CcSEcCtD
Pimecrolimus—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000959	0.0021	CcSEcCtD
Pimecrolimus—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000957	0.0021	CcSEcCtD
Pimecrolimus—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000957	0.0021	CcSEcCtD
Pimecrolimus—Angioedema—Prednisone—ankylosing spondylitis	0.000951	0.00208	CcSEcCtD
Pimecrolimus—Eye disorder—Methotrexate—ankylosing spondylitis	0.000934	0.00205	CcSEcCtD
Pimecrolimus—Urticaria—Prednisolone—ankylosing spondylitis	0.000929	0.00203	CcSEcCtD
Pimecrolimus—Pain—Triamcinolone—ankylosing spondylitis	0.000919	0.00201	CcSEcCtD
Pimecrolimus—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000903	0.00198	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000901	0.00197	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000889	0.00195	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000889	0.00195	CcSEcCtD
Pimecrolimus—Arthralgia—Prednisone—ankylosing spondylitis	0.000886	0.00194	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00088	0.00193	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000877	0.00192	CcSEcCtD
Pimecrolimus—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000876	0.00192	CcSEcCtD
Pimecrolimus—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000876	0.00192	CcSEcCtD
Pimecrolimus—Malnutrition—Methotrexate—ankylosing spondylitis	0.00087	0.00191	CcSEcCtD
Pimecrolimus—Erythema—Methotrexate—ankylosing spondylitis	0.00087	0.00191	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000861	0.00189	CcSEcCtD
Pimecrolimus—Urticaria—Triamcinolone—ankylosing spondylitis	0.000854	0.00187	CcSEcCtD
Pimecrolimus—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000852	0.00187	CcSEcCtD
Pimecrolimus—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00085	0.00186	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00085	0.00186	CcSEcCtD
Pimecrolimus—Oedema—Prednisone—ankylosing spondylitis	0.00085	0.00186	CcSEcCtD
Pimecrolimus—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000848	0.00186	CcSEcCtD
Pimecrolimus—Infection—Prednisone—ankylosing spondylitis	0.000844	0.00185	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000842	0.00184	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000842	0.00184	CcSEcCtD
Pimecrolimus—Back pain—Methotrexate—ankylosing spondylitis	0.000842	0.00184	CcSEcCtD
Pimecrolimus—Pain—Dexamethasone—ankylosing spondylitis	0.000834	0.00183	CcSEcCtD
Pimecrolimus—Pain—Betamethasone—ankylosing spondylitis	0.000834	0.00183	CcSEcCtD
Pimecrolimus—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000833	0.00182	CcSEcCtD
Pimecrolimus—Skin disorder—Prednisone—ankylosing spondylitis	0.000825	0.00181	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000798	0.00175	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000798	0.00175	CcSEcCtD
Pimecrolimus—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000792	0.00173	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00079	0.00173	CcSEcCtD
Pimecrolimus—Urticaria—Betamethasone—ankylosing spondylitis	0.000775	0.0017	CcSEcCtD
Pimecrolimus—Urticaria—Dexamethasone—ankylosing spondylitis	0.000775	0.0017	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000774	0.0017	CcSEcCtD
Pimecrolimus—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000771	0.00169	CcSEcCtD
Pimecrolimus—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000771	0.00169	CcSEcCtD
Pimecrolimus—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000771	0.00169	CcSEcCtD
Pimecrolimus—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000771	0.00169	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisone—ankylosing spondylitis	0.000763	0.00167	CcSEcCtD
Pimecrolimus—Pruritus—Triamcinolone—ankylosing spondylitis	0.000761	0.00167	CcSEcCtD
Pimecrolimus—Cough—Methotrexate—ankylosing spondylitis	0.000759	0.00166	CcSEcCtD
Pimecrolimus—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000759	0.00166	CcSEcCtD
Pimecrolimus—Arthralgia—Methotrexate—ankylosing spondylitis	0.000741	0.00162	CcSEcCtD
Pimecrolimus—Rash—Prednisolone—ankylosing spondylitis	0.000737	0.00161	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisolone—ankylosing spondylitis	0.000736	0.00161	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000736	0.00161	CcSEcCtD
Pimecrolimus—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000734	0.00161	CcSEcCtD
Pimecrolimus—Headache—Prednisolone—ankylosing spondylitis	0.000732	0.0016	CcSEcCtD
Pimecrolimus—Constipation—Prednisone—ankylosing spondylitis	0.000727	0.00159	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00071	0.00156	CcSEcCtD
Pimecrolimus—Infection—Methotrexate—ankylosing spondylitis	0.000705	0.00154	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000696	0.00152	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000695	0.00152	CcSEcCtD
Pimecrolimus—Nausea—Prednisolone—ankylosing spondylitis	0.000694	0.00152	CcSEcCtD
Pimecrolimus—Pruritus—Betamethasone—ankylosing spondylitis	0.00069	0.00151	CcSEcCtD
Pimecrolimus—Pruritus—Dexamethasone—ankylosing spondylitis	0.00069	0.00151	CcSEcCtD
Pimecrolimus—Skin disorder—Methotrexate—ankylosing spondylitis	0.00069	0.00151	CcSEcCtD
Pimecrolimus—Vomiting—Triamcinolone—ankylosing spondylitis	0.000684	0.0015	CcSEcCtD
Pimecrolimus—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000682	0.00149	CcSEcCtD
Pimecrolimus—Rash—Triamcinolone—ankylosing spondylitis	0.000678	0.00148	CcSEcCtD
Pimecrolimus—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000677	0.00148	CcSEcCtD
Pimecrolimus—Rash—Methylprednisolone—ankylosing spondylitis	0.000676	0.00148	CcSEcCtD
Pimecrolimus—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000676	0.00148	CcSEcCtD
Pimecrolimus—Urticaria—Prednisone—ankylosing spondylitis	0.000675	0.00148	CcSEcCtD
Pimecrolimus—Headache—Triamcinolone—ankylosing spondylitis	0.000674	0.00148	CcSEcCtD
Pimecrolimus—Headache—Methylprednisolone—ankylosing spondylitis	0.000672	0.00147	CcSEcCtD
Pimecrolimus—Abdominal pain—Prednisone—ankylosing spondylitis	0.000672	0.00147	CcSEcCtD
Pimecrolimus—Body temperature increased—Prednisone—ankylosing spondylitis	0.000672	0.00147	CcSEcCtD
Pimecrolimus—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000667	0.00146	CcSEcCtD
Pimecrolimus—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000667	0.00146	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000647	0.00142	CcSEcCtD
Pimecrolimus—Nausea—Triamcinolone—ankylosing spondylitis	0.000639	0.0014	CcSEcCtD
Pimecrolimus—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000638	0.0014	CcSEcCtD
Pimecrolimus—Nausea—Methylprednisolone—ankylosing spondylitis	0.000637	0.0014	CcSEcCtD
Pimecrolimus—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000633	0.00139	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000626	0.00137	CcSEcCtD
Pimecrolimus—Vomiting—Betamethasone—ankylosing spondylitis	0.00062	0.00136	CcSEcCtD
Pimecrolimus—Vomiting—Dexamethasone—ankylosing spondylitis	0.00062	0.00136	CcSEcCtD
Pimecrolimus—Rash—Dexamethasone—ankylosing spondylitis	0.000615	0.00135	CcSEcCtD
Pimecrolimus—Rash—Betamethasone—ankylosing spondylitis	0.000615	0.00135	CcSEcCtD
Pimecrolimus—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000615	0.00135	CcSEcCtD
Pimecrolimus—Dermatitis—Betamethasone—ankylosing spondylitis	0.000615	0.00135	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000613	0.00134	CcSEcCtD
Pimecrolimus—Headache—Betamethasone—ankylosing spondylitis	0.000611	0.00134	CcSEcCtD
Pimecrolimus—Headache—Dexamethasone—ankylosing spondylitis	0.000611	0.00134	CcSEcCtD
Pimecrolimus—Pain—Methotrexate—ankylosing spondylitis	0.000607	0.00133	CcSEcCtD
Pimecrolimus—Pruritus—Prednisone—ankylosing spondylitis	0.000601	0.00132	CcSEcCtD
Pimecrolimus—Diarrhoea—Prednisone—ankylosing spondylitis	0.000581	0.00127	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000581	0.00127	CcSEcCtD
Pimecrolimus—Nausea—Dexamethasone—ankylosing spondylitis	0.000579	0.00127	CcSEcCtD
Pimecrolimus—Nausea—Betamethasone—ankylosing spondylitis	0.000579	0.00127	CcSEcCtD
Pimecrolimus—Urticaria—Methotrexate—ankylosing spondylitis	0.000564	0.00124	CcSEcCtD
Pimecrolimus—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000561	0.00123	CcSEcCtD
Pimecrolimus—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000561	0.00123	CcSEcCtD
Pimecrolimus—Vomiting—Prednisone—ankylosing spondylitis	0.00054	0.00118	CcSEcCtD
Pimecrolimus—Rash—Prednisone—ankylosing spondylitis	0.000536	0.00117	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisone—ankylosing spondylitis	0.000535	0.00117	CcSEcCtD
Pimecrolimus—Headache—Prednisone—ankylosing spondylitis	0.000532	0.00117	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000523	0.00115	CcSEcCtD
Pimecrolimus—Nausea—Prednisone—ankylosing spondylitis	0.000505	0.00111	CcSEcCtD
Pimecrolimus—Pruritus—Methotrexate—ankylosing spondylitis	0.000502	0.0011	CcSEcCtD
Pimecrolimus—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000486	0.00106	CcSEcCtD
Pimecrolimus—Vomiting—Methotrexate—ankylosing spondylitis	0.000451	0.000989	CcSEcCtD
Pimecrolimus—Rash—Methotrexate—ankylosing spondylitis	0.000448	0.00098	CcSEcCtD
Pimecrolimus—Dermatitis—Methotrexate—ankylosing spondylitis	0.000447	0.00098	CcSEcCtD
Pimecrolimus—Headache—Methotrexate—ankylosing spondylitis	0.000445	0.000974	CcSEcCtD
Pimecrolimus—Nausea—Methotrexate—ankylosing spondylitis	0.000422	0.000924	CcSEcCtD
